Drug Approval | July 18, 2022
Orchid Pharma updates on PLI scheme benefits for its subsidiary
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
Manish led SeQuent since 2014 and played a major role in transforming the company
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
Site Enhances New Modality CRDMO Platform Capacity for Customers
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.
The AICVD tool can predict the risk of cardiovascular disease.
Govt committed to supporting pharma companies with industry-friendly policies
Subscribe To Our Newsletter & Stay Updated
